Scientists at the Children's Medical Center Research Institute at UT Southwestern in Dallas, TX, have uncovered a new bone-forming growth factor that may reverse the bone loss associated with osteoporosis. They say that this discovery has implications for regenerative medicine.
[bone fracture of the spine]
Osteolectin has been shown to promote bone growth in postmenopausal mice.

Osteoporosis develops over several years and is a condition that weakens bones. This weakness makes bones more fragile and susceptible to breakages. More than 50 million people in the United States aged 50 and older are affected by osteoporosis or low bone mass.

Visit Original Source